ARCHIVES

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

A Texas Radiation Center’s Survival Move Draws M.D. Anderson Into PPM Competition

February 27, 1998

Panel to Hear Innovation Reports

August 26, 1988

Local Labs Not As Accurate As Central Testing For HER2

August 30, 2002

RFP Available; Program Announcement

April 16, 1993

Lagging Government Salaries Spur NCI Turnover Among Senior Staff, Threaten Cancer Program

September 5, 1975

Small But Valued NIH Grant Program Cut In FY92 Budget

April 12, 1991